Distribution of secretory inhibitor of platelet microbicidal protein among urethral isolates with its correlation

Iuri B Ivanov1, Viktor A Gritsenko, Michael D Kuzmin

  • 1Department of Human Microbiology, Institute of Cellular and Intracellular Symbiosis, Russian Academy of Sciences, Volgogradskaya Street 36/3, Orenburg, Russia. ubi@mail.orb.ru

Asian Journal of Andrology
|December 22, 2007
PubMed
Abstract

Insights

Secretory inhibitor of platelet microbicidal protein (SIPMP) phenotypes were detected in urethral bacteria. Higher SIPMP levels were found in bacteria from chronic bacterial prostatitis (CBP) patients, suggesting an association with CBP pathogenesis.

Area of Science:

  • Microbiology
  • Urology
  • Immunology

Background:

  • Chronic bacterial prostatitis (CBP) is a challenging condition.
  • The role of bacterial virulence factors in CBP is not fully understood.
  • Platelet microbicidal proteins (PMPs) are key components of innate immunity.

Purpose of the Study:

  • To detect secretory inhibitor of platelet microbicidal protein (SIPMP) phenotypes in urethral bacterial isolates.
  • To compare SIPMP production in isolates from patients with and without CBP.
  • To explore the potential link between SIPMP and CBP pathogenesis.

Main Methods:

  • Urethral isolates including Staphylococcus spp., diphtheroids, micrococci, streptococci, Enterobacteriaceae, and Enterococcus faecalis were tested.
  • SIPMP production was assessed by measuring the inhibition of PMP bioactivity against Bacillus subtilis.
  • Results were quantified as the percentage of inhibition of PMP's bactericidal activity.

Main Results:

  • A significantly higher proportion of CBP-associated strains (57.78%) inhibited PMP activity compared to non-CBP strains (16.67%).
  • Staphylococci and Enterococcus faecalis isolates from CBP patients exhibited significantly higher SIPMP levels than controls.
  • These findings indicate a strong association between SIPMP production and CBP.

Conclusions:

  • SIPMP production by urethral bacteria is significantly associated with chronic bacterial prostatitis.
  • The detection of SIPMP phenotypes may offer insights into the pathogenesis of CBP.
  • Further research into SIPMP's role could inform novel therapeutic strategies for CBP.

Related Concept Videos

Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...